Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 Signaling-Reference-Cited by-同舟云学术

Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 Signaling

Published:2010-11 Issue:5 Volume:18 Page:524-535
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Chen Edwin,Beer Philip A.,Godfrey Anna L.,Ortmann Christina A.,Li Juan,Costa-Pereira Ana P.,Ingle Catherine E.,Dermitzakis Emmanouil T.,Campbell Peter J.,Green Anthony R.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference63 articles.

1. Polycythemia vera: stem-cell and probable clonal origin of the disease;Adamson;N. Engl. J. Med.,1976

2. Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease;Akada;Blood,2010

3. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection;Baldridge;Nature,2010

4. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

5. Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F;Berkofsky-Fessler;Clin. Cancer Res.,2010

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased CXCL10 (IP-10) is associated with advanced myeloproliferative neoplasms and its loss dampens erythrocytosis in mouse models;Experimental Hematology;2024-07

2. Novel germline JAK2^R715T mutation causing PV‐like erythrocytosis in 3 generations. Amelioration by Ropeg‐Interferon;American Journal of Hematology;2024-04-17

3. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management;American Journal of Hematology;2024-01-25

4. Preleukemic single-cell landscapes reveal mutation-specific mechanisms and gene programs predictive of AML patient outcomes;Cell Genomics;2023-12

5. Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia;Cancer Discovery;2023-05-16